The absence of increased pmTOR in GDM-D placentas highlights a differential regulatory effect depending on the treatment modality, possibly due to lower insulin exposure and the absence of exogenous insulin stimulation, which could have implications for fetal growth outcomes in GDM. This evidence concerns the gene INS and gestational diabetes.